The binding of fibrinogen to platelets occurs according to the law of mass action. The platelet receptor binds reversibly a single fibrinogen molecule and undergoes a conformational transition between two allosteric states, T and R, that differ in their affinity for fibrinogen. The equilibrium between the two forms is shifted by ADP toward the R (high-affinity) state, thus promoting the aggregation process.
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This model opens the way to consideration of allosteric modulation of the binding of fibrinogen to its platelet receptor.
Fibrinogen binding to activated platelets is a fundamental physiological process that underlies platelet aggregation. The platelet receptor for fibrinogen is constituted by two glycoproteins, the GpIIb-IIIa heterodimer complex (1) . In the absence of activating molecules, such as ADP, fibrinogen binding to platelets is negligible, notwithstanding the presence of the receptor on the platelet membrane (2) . This suggests that upon activation the receptor undergoes a conformational transition by which fibrinogen is bound with high affinity, leading to platelet aggregation. To test this hypothesis, binding data need to be collected over a wide range of fibrinogen activity and for different values of ADP concentration. In this paper we report experimental evidence that suggests the existence of allosteric equilibria in the binding of fibrinogen to its platelet receptor. The approach taken here allows one to cast the study of this biologically relevant reaction in terms of the principles of linkage thermodynamics (3, 4) and their mechanistic interpretation according to the allosteric model (5) .
MATERIALS AND METHODS
Preparation of Platelets. Venous blood from healthy donors was collected in plastic tubes containing sodium citrate (final concentration, 0.38%) as anticoagulant. Platelet-rich plasma was obtained by centrifugation at 120 x g for 20 min. To remove all adsorbed fibrinogen, platelets were repeatedly gel-filtered on 25 x 1.5-cm Sepharose 2B columns equilibrated with Hepes-buffered modified Tyrode's solution, pH 7.2, at 37°C, containing 0.2% bovine serum albumin, 0.13 M NaCl, 2.6 mM KCI, 0.39 mM NaH2PO4, 12 mM NaHCO3, 10 mM Hepes, and 5.5 mM glucose. Platelet concentration was adjusted to about 2 x 108 per ml. Platelets were counted electronically by a TOA PL 100 platelet counter (Medical Electronics, Japan).
Preparation of Fibrinogen. Human adult fibrinogen (grade L) was from Kabi was purified by gelatin-Sepharose 4B affinity chromatography to remove contaminating fibronectin. The purity (99%) was assessed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis performed under both reducing and nonreducing conditions. The fibrinogen concentration was measured spectrophotometrically by using an extinction coefficient A""JD = 1.51 (6) . Clottability of the preparation as assessed by purified a-thrombin was >90%. Fibrinogen solution aliquots were stored at -70'C until use. Purified human fibrinogen was then labeled with carrier-free Na125I by the Iodo-Gen technique (7) . The specific activity of 125I-labeled fibrinogen ranged between 20 and 50 p.Ci/mg of protein (1 0Ci = 37 kBq). Clottability of fibrinogen was not affected by the labeling procedure. A Packard 240 CGD automatic y counter was used for all determinations.
Fibrinogen Binding Studies. 125I-labeled fibrinogen binding to gel filtered platelets was assessed as described (8) The data, taken as radioactivity in cpm, C, with changes in the fibrinogen activity were analyzed accordingly as follows:
where 0 is the fractional saturation of the receptor with fibrinogen, and CO and C1 are the cpm for 0 = 0 and 0 = 1, respectively. Eq. 1 is the exact parallel of that used in the analysis of binding data obtained by spectroscopic methods (9) . The amount of free fibrinogen, x, was determined by subtracting the amount bound, which was linearly related to the experimental values of C, from the total. The function 6 was expressed as follows:
Here 1i is the overall equilibrium constant for the reaction M + iX -+ MXj (f30 = 1), where M and X denote the receptor and fibrinogen, respectively. The constant n represents the total number of fibrinogen binding sites of the receptor.
The use of Eqs. 1 and 2 implies that the binding of fibrinogen to its platelet receptor occurs according to the law of mass action and consequently shows saturation (4) . The Abbreviation: GpIIb-IIIa, glycoprotein IIb-II1a.
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existence of aspecific binding offibrinogen to platelets would not lead to saturation (4). This possibility was taken into account in the fitting procedure and was statistically tested by F-testing. The binding data were analyzed according to Eq. 1 by a nonlinear least-squares procedure using a modified Marquardt algorithm. The x2 value was minimized in the parameter space by using a uniform weighting procedure consistent with the distribution of errors found experimentally. For each data set the minimization was carried out for different values of n (up to n = 4) to determine possible cooperativity in the binding reaction. Confidence intervals on all parameters were determined by F-testing. The experimental binding data taken at different ADP concentrations were then analyzed simultaneously by assuming common values of CO and C1 and by using for 6 (3, 4) , which are independent of the particular experimental procedure used to establish the facts. The linkage between ADP and fibrinogen binding is quantified from the slope ofthe curve in Fig. 2 , where the logarithm of the overall association constant p1 is plotted as a function of the logarithm of ADP activity. The maximum slope is observed in the micromolar range of fibrinogen concentration and is equal to 0.6 mole of ADP per mole of fibrinogen bound. The linkage is positive, and therefore ADP binding promotes fibrinogen binding and vice versa. Further, a single ADP molecule appears to be sufficient to describe the linkage, and the overall equilibrium constant for fibrinogen binding can be written as logPI = log P (1 + aly) [5] where 13? is the value of ,1 in the absence of ADP, a, and a.
are the equilibrium constants for ADP binding to platelets in the presence and absence of fibrinogen, respectively, and y is the ADP activity. The dissociation constants for ADP binding to platelets in the presence and absence of fibrinogen can be obtained from analysis of the data shown in Fig. 2 that the GpIIb-IIIa complex is totally inaccessible to fibrinogen in the absence of ADP and is exposed upon activation. The model introduced here assumes that the receptor is virtually inaccessible only in the T state. Since this state is in equilibrium with the high-affinity R state, fibrinogen binds specifically to platelets even in the absence of ADP.
The allosteric equilibria between the two states of the receptor are modulated by ADP in a complex fashion. This molecule does not bind to the GpIIb-IIIa complex (13) , and thus the linkage between ADP and fibrinogen binding is not direct. It can be considered a pseudolinkage (14) mediated by a third component. In this case ADP binding to platelets affects the third component, which in turn induces a conformational change in the fibrinogen receptor (Fig. 3) . Isolation of the component responsible for the pseudolinkage is of critical importance in further elucidating the allosteric modulation of fibrinogen binding to its receptor by ADP or other effector molecules. Preliminary investigation indicates that the Na+/H' antiport may be involved in the pseudolinkage between ADP and fibrinogen binding.
The consistency found between the binding data and the allosteric model presented here is attractive. It opens the way to consideration of allosteric effects in the aggregation process and their pharmacological control. In addition, it provides a simple conceptual framework by which different platelet dysfunctions might be discussed and perhaps rationalized according to the principles oflinkage thermodynamics. This work was supported by National Science Foundation Grant PCM772062 (J.W.). E.DiC. gratefully acknowledges financial support from National Institutes of Health Grant HL22325 during his stay at the University of Colorado in Boulder.
